Loading clinical trials...
Loading clinical trials...
Age-related macular degeneration (AMD) remains a leading cause of blindness in United States and can be broadly divided into two forms: non-neovascular AMD (NNVAMD) and neovascular AMD (NVAMD) AMD. Am...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Johns Hopkins University
Collaborators
NCT07440225 · Macular Degeneration, Age-Related Macular Degeneration, and more
NCT06132035 · Age-related Wet Macular Degeneration
NCT03999801 · Neovascular Age-related Macular Degeneration, Wet Macular Degeneration
NCT04420923 · Wet Macular Degeneration
NCT05637255 · Wet Macular Degeneration, Neovascular Age-related Macular Degeneration, and more
Wilmer Eye Institute at Johns Hopkins University
Baltimore, Maryland
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions